Characteristics of Colorectal Mucinous Adenocarcinoma in Iran

被引:1
|
作者
Safaee, Azadeh [1 ]
Moghimi-Dehkordi, Bijan [1 ]
Fatemi, S. R. [1 ]
Ghiasi, S. [1 ]
Nemati-Malek, F. [1 ]
Zali, M. R. [1 ]
机构
[1] Shahid Beheshti Univ MC, Res Ctr Gastroenterol & Liver Dis, Tehran, Iran
关键词
Mucinous adenocarcinoma colorectal cancer; right colon; stage; family history; CARCINOMA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and Background: Mucinous adenocarcinoma (MA) colorectal cancer accounts for 10 to 15% of colorectal carcinoma. It is generally thought that patients with MA present at a more advanced stage of disease and have a poorer prognosis than those with other types of carcinoma The purpose of the present study was to clarify the clinicopathological characteristics of mucinous colorectal carcinoma in the Iranian population. Methods: Between January 2002 and March 2008, Of the 1283 colorectal cancer patients, 110 patients were considered to have mucinous tumors according to pathology report. Patients evaluated on the basis of sex, age, location of tumor, stage, differentiation of tumor and family history of cancer. Kaplan-Meier curves and log-rank tests were used for survival analysis. Results: The median age of these patients at diagnosis was 50.07 years. More than 50% of patients were younger than aged 50 years. 34.5% of patients had a family history of colorectal cancer in their first-degree relatives. Most tumors were presented in right colon. 54.3% of MA patients had advanced Stage lesions. The Kaplan-Meier method indicated that, the 1, 3 and 5years survival rates are 92.6, 80.1 and 41.3 percent, respectively. Survival of the patients was related to disease stage (P = 0.023). Conclusion: Our suggests that genetic factors may be play an important role in the development of this disease in our country and screening programs, especially genetic screening programs, should be considered as a main measure for prevention and control of colorectal cancer in Iran.
引用
收藏
页码:1373 / 1375
页数:3
相关论文
共 50 条
  • [21] Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer
    Ian S. Reynolds
    Emer O’Connell
    Michael Fichtner
    Deborah A. McNamara
    Elaine W. Kay
    Jochen H. M. Prehn
    Simon J. Furney
    John P. Burke
    The Pharmacogenomics Journal, 2020, 20 : 524 - 532
  • [22] Integrated transcriptome and methylome analysis of mucinous colorectal adenocarcinoma
    Ab Mutalib, Nurul-Syakima
    Baharuddin, Rasyidah
    Abdullah, Noraidatulakma
    Mazlan, Luqman
    Jamal, Rahman
    HUMAN GENOMICS, 2018, 12
  • [23] Colorectal mucinous adenocarcinoma: Proposal of a novel grading system
    Barresi, V.
    Bonetti, L. Reggiani
    Ieni, A.
    Tuccari, G.
    VIRCHOWS ARCHIV, 2015, 467 : S1 - S1
  • [24] Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer
    Reynolds, Ian S.
    O'Connell, Emer
    Fichtner, Michael
    McNamara, Deborah A.
    Kay, Elaine W.
    Prehn, Jochen H. M.
    Furney, Simon J.
    Burke, John P.
    PHARMACOGENOMICS JOURNAL, 2020, 20 (03): : 524 - 532
  • [25] Is Livin a protagonist of mucinous adenocarcinoma histology in colorectal cancer
    Faruk, Mohammed
    Rafindadi, Abdulmumini Hassan
    Ibrahim, Sani
    Aminu, Surajo Mohammed
    Aminu, Surajo Mohammed
    Adamu, Ahmed
    Adamu, Ahmed
    Iliyasu, Yawale
    Abdullahi, Adamu
    Shehu, Mohammed Sani
    Mohammed, Abdullahi
    Idoko, John
    Randawa, Abdullahi Jibril
    Randawa, Abdullahi Jibril
    Ntekim, Atara
    Ahmed, Saad Aliyu
    Maude, Aishatu Suleiman
    Liman, Almustapha Aliyu
    Sani, Abubakar
    Shah, Khalid Zahir
    Ukwenya, Yahaya
    Ukwenya, Yahaya
    Awasum, Cheh Augustine
    Adoke, Kasimu Umar
    Enemari, James Olowu
    Enemari, James Olowu
    Enemari, James Olowu
    Nok, Andrew Jonathan
    CANCER RESEARCH, 2017, 77
  • [26] Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer
    Huang, An
    Yang, Yong
    Shi, Jing-Yi
    Li, Yu-Kun
    Xu, Jing-Xuan
    Cheng, Yu
    Gu, Jin
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 13 (12): : 1567 - 1583
  • [27] Comparison of clinicopathological characteristics of mucinous adenocarcinoma and conventional adenocarcinoma of gallbladder
    Zou, Rui-Qi
    Hu, Hai-Jie
    Liu, Fei
    Lv, Tian-Run
    Wang, Jun-Ke
    Regmi, Parbatraj
    Li, Fu-Yu
    ASIAN JOURNAL OF SURGERY, 2023, 46 (01) : 283 - 290
  • [28] Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma
    Saad, RS
    Cho, P
    Silverman, JF
    Liu, YL
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (03) : 421 - 427
  • [29] Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival
    Lee, Chung-Ta
    Huang, Yu-Chuan
    Hung, Liang-Yi
    Chow, Nan-Haw
    Su, Pei-Fang
    Ho, Chung-Liang
    Tsai, Hung-Wen
    Chen, Yi-Lin
    Lin, Shao-Chieh
    Lin, Bo-Wen
    Lin, Peng-Chan
    Lee, Jenq-Chang
    ONCOTARGET, 2017, 8 (21) : 35165 - 35175
  • [30] Clinical characteristics of mucinous adenocarcinoma of the ovary.
    Shimada, M
    Kigawa, J
    Nishimura, R
    Suzuki, M
    Kita, T
    Sugiyama, T
    Hiura, M
    Kaku, T
    Tsuda, H
    Terakawa, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 469S - 469S